|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 641.00 GBX | 0.00% |
|
+3.55% | +52.62% |
| 12-08 | JPMorgan cuts M&G, UBS cuts Trainline | AN |
| 10-20 | Oxford Biomedica plc Announces Stepping Down of Robert Ghenchev as Non-Executive Director, Effective October 20, 2025 | CI |
| Capitalization | 773M 1.04B 882M 824M 1.43B 93.52B 1.56B 9.6B 3.73B 44.18B 3.89B 3.81B 161B | P/E ratio 2025 * |
-21.5x | P/E ratio 2026 * | -230x |
|---|---|---|---|---|---|
| Enterprise value | 745M 1B 851M 794M 1.38B 90.19B 1.5B 9.25B 3.6B 42.6B 3.75B 3.67B 155B | EV / Sales 2025 * |
4.55x | EV / Sales 2026 * | 3.39x |
| Free-Float |
76.07% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Oxford Biomedica plc
| 1 day | -0.16% | ||
| 1 week | +3.55% | ||
| Current month | +1.75% | ||
| 1 month | +4.06% | ||
| 3 months | +6.83% | ||
| 6 months | +95.73% | ||
| Current year | +52.62% |
| 1 week | 613 |  | 656 |
| 1 month | 577 | | 656 |
| Current year | 232.5 | | 685 |
| 1 year | 232.5 | | 685 |
| 3 years | 164.29 | | 685 |
| 5 years | 164.29 | | 1,678 |
| 10 years | 148.88 | | 1,678 |
| Manager | Title | Age | Since |
|---|---|---|---|
Frank Mathias
CEO | Chief Executive Officer | 63 | 26/03/2023 |
Lucinda Crabtree
DFI | Director of Finance/CFO | 46 | 01/09/2024 |
Thierry Cournez
COO | Chief Operating Officer | - | 30/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Heather Preston
BRD | Director/Board Member | 59 | 14/03/2018 |
| Chairman | 69 | 23/06/2020 | |
Dame Davies
BRD | Director/Board Member | 74 | 28/02/2021 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0% | 51 M€ | +19.39% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | +3.55% | +49.07% | +72.78% | 1.03B | |
| -1.74% | -4.47% | +30.44% | +99.68% | 54.9B | |
| +2.40% | -5.42% | +161.37% | +901.21% | 40.49B | |
| +0.70% | +6.60% | +61.12% | +16.75% | 39.05B | |
| -0.35% | -0.32% | -19.81% | -42.57% | 23.02B | |
| +2.74% | -0.78% | +33.20% | -37.07% | 19.13B | |
| -0.30% | +8.84% | +83.35% | -37.88% | 17.81B | |
| +0.51% | -0.68% | +83.44% | +186.34% | 13.83B | |
| +0.17% | -4.52% | -4.32% | +536.88% | 13.83B | |
| +1.31% | -3.33% | +123.20% | - | 12.35B | |
| Average | +0.53% | -0.79% | +60.11% | +188.46% | 23.54B | |
| Weighted average by Cap. | +0.40% | -1.67% | +63.38% | +225.61% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 164M 220M 187M 174M 303M 19.81B 329M 2.03B 790M 9.36B 824M 807M 34.1B | 226M 303M 258M 241M 418M 27.34B 455M 2.8B 1.09B 12.91B 1.14B 1.11B 47.05B |
| Net income | -33.24M -44.61M -37.95M -35.43M -61.47M -4.02B -66.92M -413M -160M -1.9B -167M -164M -6.93B | -5.23M -7.01M -5.97M -5.57M -9.67M -633M -10.52M -64.92M -25.22M -299M -26.32M -25.76M -1.09B |
| Net Debt | -27.53M -36.95M -31.43M -29.35M -50.91M -3.33B -55.43M -342M -133M -1.57B -139M -136M -5.74B | -6.15M -8.26M -7.03M -6.56M -11.38M -745M -12.39M -76.43M -29.7M -352M -30.99M -30.34M -1.28B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/12/25 | 641.00 p | 0.00% | 121,193 |
| 10/12/25 | 641.00 p | +0.16% | 433,002 |
| 09/12/25 | 640.00 p | -0.62% | 147,439 |
| 08/12/25 | 644.00 p | +4.04% | 168,604 |
| 05/12/25 | 619.00 p | 0.00% | 134,753 |
Delayed Quote London S.E., December 11, 2025 at 04:35 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- OXB Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition